11 Mar 2026Open access
Photodynamic therapy based on indomethacin-conjugated photosensitizers: targeting cyclooxygenase-2 in cancer treatmentPublisher siteMedical Gas Research, Photodynamic Therapy Research Studies
UniversitiesKalayou Hiluf Gebremedhin
Active, last published 2026
Kalayou Hiluf
Gebremedhin
Scholar“Research profile drawn from open scholarly records.”
Mekelle University
Claim Your Profile2
H-index
19
Citations
Kalayou has not officially claimed their profile. If you are Kalayou, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Kalayou Hiluf Gebremedhin will appear here once their profile is updated.
02 · Reach
Publication output and reach
Kalayou's work has been cited 19 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchMekelle UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
3 works22 Nov 2025Open access2cites
Synergistic adsorption-photocatalysis effect of CuO/TiO2 composite for high-efficient degradation of methyl orangePublisher siteDiscover Nano, Copper-based nanomaterials and applications
29 Feb 2024Open access17cites
Nanomaterial-based optical colorimetric sensors for rapid monitoring of inorganic arsenic species: a reviewPublisher siteDiscover Nano, Arsenic contamination and mitigation
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Kalayou?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you